See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $997B | 15.7x | 34.6x | |
| $527B | 5.6x | 14.8x | |
| $470B | 7.7x | 18.3x | |
| $291B | 5.2x | 12.7x | |
| $288B | 4.4x | 9.7x | |
| $250B | 5.7x | 22.4x | |
| $224B | 6.2x | 12.7x | |
| $189B | 3.0x | 7.6x | |
| $178B | 7.3x | 23.3x | |
| $172B | 5.9x | 10.8x | |
| $146B | 3.0x | 7.8x | |
| $118B | 2.7x | 8.0x | |
| $113B | 9.4x | 21.0x | |
| $83.0B | 10.4x | 20.5x | |
| $80.1B | 1.5x | 7.1x | |
| $76.8B | 5.4x | 15.3x | |
| $74.3B | 2.6x | 9.5x | |
| $72.6B | 2.9x | 10.1x | |
| $65.1B | 4.1x | 12.1x | |
| $60.8B | 6.4x | 14.8x | |
| $53.8B | 6.2x | 20.1x | |
| $52.0B | 11.1x | 36.7x | |
| $51.5B | 13.8x | 73.8x | |
| $31.8B | 14.3x | -96.0x | |
| $27.7B | 2.0x | 6.7x | |
| $26.9B | 2.1x | 8.9x | |
| $26.3B | 7.5x | 24.6x | |
| $25.5B | 2.3x | 11.6x | |
| $24.7B | 11.8x | 30.5x | |
| $23.9B | 8.0x | 8.2x | |
| $20.6B | 7.6x | 31.9x | |
| $19.5B | 61.5x | 36.3x | |
| $17.0B | 8.7x | 83.8x | |
| $12.2B | 13.6x | -33.0x | |
| $11.6B | 5.0x | 12.3x | |
| $11.0B | 2.5x | 6.5x | |
| $10.6B | 3.4x | 14.0x | |
| $10.6B | 3.2x | 7.6x | |
| $10.5B | 1.5x | 8.5x | |
| $10.3B | 5.0x | 13.5x | |
| $9.6B | 1.5x | 12.1x | |
| $9.5B | 7.8x | 22.1x | |
| $9.0B | 466.1x | -13.4x | |
| $7.9B | n/a | n/a | |
| $7.6B | 12.1x | -46.0x | |
| $7.4B | 96.0x | 32582.7x | |
| $7.1B | n/a | -17.4x | |
| $6.6B | 17.0x | 39.3x | |
| $6.6B | 2.2x | 9.6x | |
| $6.5B | 934014.6x | n/a | |
| $6.5B | 13.5x | 44.4x | |
| $6.3B | 2.0x | 8.3x | |
| $6.1B | 114.1x | -19.3x | |
| $5.9B | n/a | n/a | |
| $5.7B | n/a | -21.3x | |
| $5.5B | 6.3x | 22.2x | |
| $5.4B | 9.0x | 27.0x | |
| $5.0B | 2.8x | 5.3x | |
| $5.0B | 8.3x | 36.3x | |
| $5.0B | 1.8x | 4.9x | |
| $5.0B | 74.9x | -34.5x | |
| $5.0B | 1.4x | 8.6x | |
| $4.9B | 3.4x | 10.4x | |
| $4.7B | 9.1x | 23.7x | |
| $4.7B | 3.1x | 8.6x | |
| $4.6B | 5.4x | 27.6x | |
| $4.6B | 3.8x | 15.1x | |
| $4.6B | n/a | -8.9x | |
| $4.5B | 4.8x | 13.3x | |
| $4.4B | n/a | -11.1x | |
| $4.4B | 6.3x | n/a | |
| $4.0B | 3.9x | 17.9x | |
| $3.8B | 3.0x | 16.8x | |
| $3.7B | 4.0x | 16.3x | |
| $3.7B | 2.1x | 10.6x | |
| $3.6B | 13.8x | 34.1x | |
| $3.6B | 3.5x | -27.9x | |
| $3.6B | n/a | n/a | |
| $3.5B | 431.7x | -6.3x | |
| $3.3B | 4.9x | 14.4x | |
| $3.2B | n/a | n/a | |
| $3.1B | 3.5x | 14.2x | |
| $2.9B | 3.6x | 75.2x | |
| $2.7B | 4.0x | 16.5x | |
| $2.7B | 3.9x | 21.2x | |
| $2.5B | 4.0x | 13.1x | |
| $2.5B | 37.8x | -79.5x | |
| $2.4B | 43.9x | -9.0x | |
| $2.3B | 3.0x | 15.8x | |
| $2.2B | 1.6x | 10.7x | |
| $2.2B | 1.7x | 9.3x | |
| $2.2B | 2.0x | 9.9x | |
| $2.2B | 5.1x | -79.5x | |
| $2.1B | 5.6x | 16.3x | |
| $2.1B | 9.2x | 35.1x | |
| $2.0B | 0.8x | 6.0x | |
| $2.0B | 1.8x | 12.7x | |
| $1.9B | 2.4x | 8.7x | |
| $1.9B | 5.0x | 14.2x | |
| $1.5B | 3.7x | 11.5x |